Your browser doesn't support javascript.
loading
Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer.
Pyrgidis, Nikolaos; Vakalopoulos, Ioannis; Sountoulides, Petros.
Affiliation
  • Pyrgidis N; 1st Department of Urology, Aristotle University of Thessaloniki, 15-17 Agiou Evgeniou Street, TK 55133, Thessaloniki, Greece.
  • Vakalopoulos I; 1st Department of Urology, Aristotle University of Thessaloniki, 15-17 Agiou Evgeniou Street, TK 55133, Thessaloniki, Greece.
  • Sountoulides P; 1st Department of Urology, Aristotle University of Thessaloniki, 15-17 Agiou Evgeniou Street, TK 55133, Thessaloniki, Greece. sountp@hotmail.com.
Hormones (Athens) ; 20(1): 73-84, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33140306
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists / Antineoplastic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Humans / Male Language: En Journal: Hormones (Athens) Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists / Antineoplastic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Humans / Male Language: En Journal: Hormones (Athens) Year: 2021 Document type: Article